Stifel lowered the firm’s price target on Tesla (TSLA) to $474 from $492 and keeps a Buy rating on the shares. The firm cites the company’s ...
In a report released today, Paul Matteis from Stifel Nicolaus maintained a Buy rating on Vigil Neuroscience Inc (VIGL – Research Report), with ...
Stifel analysts increased their price target on Boston Scientific Corporation (NYSE:BSX) shares from $115.00 to $120.00, while reiterating a Buy rating for the medical device company. The adjustment ...
Stifel analysts reiterated their Buy rating on Freshpet shares (NASDAQ:FRPT), maintaining a price target of $165.00. According to InvestingPro data, analyst consensus remains strongly bullish with ...
Learn how to invest in stocks, including how to select a brokerage account and research stock market investments. Many, or all, of the products featured on this page are from our advertising ...